NDC 63552-0076-01: MELPHALAN HYDROCHLORIDE 50 mg/10mL Injection, Powder, Lyophilized, For Solution
This is a package of MELPHALAN HYDROCHLORIDE 50 mg/10mL Injection, Powder, Lyophilized, For Solution from Patheon Manufacturing Services LLC, first listed with the FDA Mar 2016 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 63552-076-01 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 63552 labeler · 076 product · 01 package
- Package marketed since
- Mar 31, 2016
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 6355207601 6
- FDA record last changed
- Oct 22, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It treats multiple myeloma, a cancer of the bone marrow. Ivra and melphalan hydrochloride for injection are used for palliative treatment when oral therapy is not appropriate. Evom...
- You will get it as an IV infusion from a healthcare team, not at home. Ivra and standard melphalan injection run over about 15 to 20 minutes on a set schedule. Evomela runs over 30...
- Low blood counts are the big one, along with diarrhea, nausea, vomiting, fatigue and low potassium. You will usually get anti-nausea medicine with it. Tell your team if the side ef...
- Call for fever or signs of infection, unusual bleeding or bruising, or yellow skin or eyes. Also call for hives, swelling, wheezing or trouble breathing, which can mean a serious a...
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Melphalan Hydrochloride — tap one for details:
Melphalan Hydrochloride may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 63552-0076-01 You're viewing this Main listing | 99 VIAL in 1 BOX / 20 mL in 1 VIAL | — | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Melphalan Hydrochloride 50 mg/10mLthis 63552-0076-01 | Patheon | 99 vials | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
The FDA lists approved generic versions of this medicine, but that does not always mean a pharmacy can get one today. Patent rules, launch agreements, supply and pricing can affect when generics actually arrive.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Melphalan inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Patheon Manufacturing Services LLC labeler code 63552
- Ruxolitinib 25 mg Tablet NDC 63552-053-00
- Carbamazepine 200 mg Tablet NDC 63552-060-05
- oseltamivir phosphate 30 mg Capsule NDC 63552-064-01
- oseltamivir phosphate 45 mg Capsule NDC 63552-065-01
- modafinil 100 mg Tablet NDC 63552-066-00
- modafinil 200 mg Tablet NDC 63552-067-00
- Peramivir 200 mg/20mL Solution NDC 63552-077-01
- Oxymorphone Hydrochloride 5 mg Tablet NDC 63552-090-00
- Oxymorphone Hydrochloride 7.5 mg Tablet NDC 63552-091-00
- Oxymorphone Hydrochloride 10 mg Tablet NDC 63552-092-00
- Oxymorphone Hydrochloride 15 mg Tablet NDC 63552-093-00
- Oxymorphone Hydrochloride 20 mg Tablet NDC 63552-094-00
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: Patheon Manufacturing Services LLC supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |